Super-response to guselkumab treatment in patients with moderate-to-severe psoriasis: age, body weight, baseline Psoriasis Area and Severity Index, and baseline Investigator's Global Assessment scores predict complete skin clearance.
Kristian ReichK B GordonBruce E StroberR G LangleyM MillerY-W YangY-K ShenY YouY ZhuP FoleyAndrew BlauveltPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2022)
Guselkumab was more likely to achieve early clinical responses (complete skin clearance) in younger patients, less obese patients and patients with less severe psoriasis.